Myeloma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Myeloma
Mar 31, 2025, 12:10 | Blog
Samer Al Hadidi: Daratumumab for high-risk smoldering multiple myeloma – Are we there yet?
Samer Al Hadidi, Associate Professor at UAMS – University of Arkansas for Medical Sciences, posted…
Mar 29, 2025, 15:50 | Blog
Mariana Fernandez: Thrilled to Have Participated in the 1st International Workshop on GPRC5D-Targeted Myeloma Therapies
Mariana Fernandez, Senior Medical Director at Global Medical Affairs Hematology at Johnson and Johnson Innovative…
Mar 29, 2025, 15:01 | Blog
Will you give up a single coffee run for a brighter future for myeloma? - International Myeloma Foundation
International Myeloma Foundation (IMF) shared a post on X: "Just $5 supports the International Myeloma…
Mar 29, 2025, 08:54 | Blog
The Leukemia and Lymphoma Society - Alfred Garfall's myeloma research is paving the way for better treatments
The Leukemia and Lymphoma Society posted on X: "Dr. Garfall’s myeloma research is paving the…
Mar 26, 2025, 08:39 | Blog
Joseph Mikhael gives his take on the necessity of the little brown jug - International Myeloma Foundation
International Myeloma Foundation posted on X: "Does UPEP research mean some myeloma patients may no…
Mar 25, 2025, 09:54 | Science
Myeloma Paper of the Day, March 25th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Mar 25, 2025, 08:26 | Blog
Ending disparities starts with understanding the why: International Myeloma Foundation
International Myeloma Foundation shared a post on LinkedIn: "Ending disparities starts with understanding the why.…
Mar 24, 2025, 10:16 | Science
Myeloma Paper of the Day, March 24th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Mar 17, 2025, 14:20 | Science
Samer Al Hadidi: Longest follow up of phase III clinical trials in myeloma
Samer Al Hadidi, Assistant professor at UAMS Myeloma Center, shared an article on X: "Longest follow…
Mar 16, 2025, 10:13 | Science
Myeloma Paper of the Day, March 16th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Mar 12, 2025, 17:09 | Blog
Deborah Pulido: A hybrid event at Sylvester Comprehensive Cancer Center with LLS
Deborah Pulido, Patient and Community Outreach Manager at the Leukemia and Lymphoma Society, shared a…
Mar 6, 2025, 08:51 | Science
Michael Wang: Triple combination ABR was effective in treatment-naïve or relapsed/refractory MCL
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
Mar 5, 2025, 12:18 | Science
Rahul Banerjee: Weng, et al examine various HRCAs in myeloma
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Feb 28, 2025, 12:20 | Science
Myeloma Paper of the Day, February 28th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Feb 25, 2025, 08:29 | Science
Maximilian Merz: What is the biology behind CAR+ T-cell lymphomas?
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared an…
Feb 23, 2025, 18:34 | Blog
Study led by ICR and University of Leeds find that 'Double Hit' Myeloma Doubles Risk of Early Progression
The Institute of Cancer Research shared a post on LinkedIn: "NEW: Research led by ICR…
Feb 15, 2025, 10:35 | Science
Myeloma Paper of the Day, February 15th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Feb 12, 2025, 07:49 | Societies
Insights from The Lymphoma, Leukemia and Myeloma Winter Symposium
The inaugural LL&M Winter Symposium, a flagship event of the Lymphoma, Leukemia & Myeloma Congress,…
Feb 11, 2025, 13:24 | Science
Myeloma Paper of the Day, February 11th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Feb 8, 2025, 15:15 | Science
Myeloma Paper of the Day, February 8th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Feb 1, 2025, 12:49 | Science
Myeloma Paper of the Day, February 1st, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 29, 2025, 13:17 | Science
Myeloma Paper of the Day, January 29th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 26, 2025, 13:10 | Science
Myeloma Paper of the Day, January 26th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 25, 2025, 04:58 | Insight
Al-Ola Abdallah: Myeloma Drug Prices
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT…
Jan 23, 2025, 11:40 | Insight
Myeloma Paper of the Day, January 23rd, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 21, 2025, 14:12 | Insight
Myeloma Paper of the Day, January 21st, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 21, 2025, 06:46 | Blog
Rahul Banerjee: Updates in chronic lymphocytic leukemia at BTFHem25
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X: “Good…
Jan 14, 2025, 15:01 | Career
OncoInfluencers to Follow on Social Media: Nico Gagelmann
We’re excited to feature Nico Gagelmann, a distinguished physician and scientist, as our next oncoinfluencer.…
Jan 14, 2025, 08:20 | Science
Nico Gagelmann: GSI: myeloma - cold case closed?
Nico Gagelmann, Co-founder of the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee,…
Jan 9, 2025, 12:14 | Blog
Rahul Gosain: Myeloma Highlights with Robert Orlowski from ASH24
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Dec 28, 2024, 18:13 | Insight
Rahul Banarjee: Excited to moderate the fiercest myeloma debate
Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington,…
Dec 28, 2024, 18:13 | Blog
The EAA173/DETER SMM Clinical Trial for Smoldering Myeloma - ECOG-ACRIN Cancer Research Group
 ECOG-ACRIN Cancer Research Group shared a post on X: "The EAA173/DETER-SMM Clinical Trial is exploring…
Dec 25, 2024, 17:52 | Blog
Rafael Fonseca: No one can guarantee outcome, but you can guarantee intent
Rafael Fonseca, Hematologist at Mayo Clinic, shared a post on X: "When writing treatment orders…
Dec 21, 2024, 22:26 | Blog
Anas Younes: Transforming outcomes for people living with Blood Cancer
Anas Younes, Senior VP, Global Head of Hematology (Early and Late Stage), Oncology R&D at…
Dec 14, 2024, 15:32 | Insight
Myeloma Paper of the Day, December 14th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Analysis of smoldering…
Dec 14, 2024, 07:31 | Blog
Aaron Goodman: Is giving Daratumumab to asymptomatic patients better than waiting until they develop cancer?
Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared…
Dec 11, 2024, 15:42 | Blog
Highlights from ASH 2024 by Rahul Banerjee
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition was held from December…
Dec 10, 2024, 23:22 | Blog
Vincent Rajkumar: Myeloma XI / XI+
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for…
Dec 9, 2024, 19:30 | Blog
Caner Saygin: How TP53-mutant CH progresses during myeloma therapy
Caner Saygin, Leukemologist at The University of Chicago, shared a post on X: "Jen Cooperrider…
Dec 8, 2024, 07:07 | Blog
Vincent Rajkumar's Annual Updated Myeloma Treatment Algorithms
 Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Dec 6, 2024, 13:45 | Insight
Myeloma Paper of the Day, December 6th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Single bout of…
Dec 5, 2024, 07:37 | Blog
Rahul Banerjee: Multiple Myeloma - Hematologic Toxicities and Advances in Quad Therapies
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Dec 3, 2024, 18:12 | Insight
Nico Gagelmann: Happy to present first European comparison of cilta-cel vs ide-cel for myeloma at ASH24
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared on X: “Happy to present first European…
Dec 3, 2024, 09:17 | Insight
UPEP 24 hour urine protein study is not necessary for response assessment in Myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared an article by…
Dec 2, 2024, 18:03 | Blog
Myeloma and AL amyloidosis highlights webinar with Charlotte Pawlyn - Myeloma Patients Europe
Myeloma Patients Europe shared a post on X: "Join us for the ASH 2024 myeloma and…
Dec 1, 2024, 22:10 | Opinion
Mike Thompson: Myeloma/Plasma Cell Dyscrasia Draft Table Update
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, posted the following on X:…
Nov 27, 2024, 14:33 | Insight
Myeloma Paper of the Day, November 27th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Study of stem-cell…
Nov 26, 2024, 21:15 | Insight
Myeloma Paper of the Day, November 26th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Comparison of outcomes…
Nov 25, 2024, 18:11 | Insight
Al-Ola A Abdallah: Early Safety and Efficacy of CAR-T Cell Therapy in Precursor Myeloma
Al-Ola A Abdallah, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas Medical Center,…
Nov 25, 2024, 16:29 | Blog
Rafael Fonseca: Improvements in overall survival for myeloma
Rafael Fonseca, Hematologist at Mayo Clinic, shared a post on X: "Just learned (source -…
Nov 22, 2024, 17:08 | Blog
Myeloma ICE documentary is a Finalist at the World Film Festival in Cannes - International Myeloma Foundation
International Myeloma Foundation shared a post on X: "Our Myeloma ICE documentary is a Finalist…
Nov 21, 2024, 16:11 | Blog
Mike Thompson: Myeloma/Plasma Cell Dyscrasia - Top Abstract Highlights from ASH24
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:…
Nov 14, 2024, 12:41 | Blog
Aaron Goodman: How to limit costs in myeloma while still providing excellent care
Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared…
Nov 10, 2024, 14:43 | Insight
Rahul Banarjee: Updated data for eque-cel fully human BCMA CAR-T in myeloma
Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington,…
Nov 9, 2024, 10:50 | Blog
Bone lesions in patients with high risk smoldering myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, posted on X…
Nov 1, 2024, 17:41 | Blog
Yelak Biru's interview with News 9 about the work IMF does
Yelak Biru, President and Chief Executive Officer at the International Myeloma Foundation, shared a post…
Oct 31, 2024, 15:16 | Insight
Myeloma Paper of the Day, October 31st, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Forimtamig, a novel…
Oct 30, 2024, 15:18 | Insight
Myeloma Paper of the Day, October 30th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Retrospective evaluation of…
Oct 29, 2024, 17:17 | Insight
Myeloma Paper of the Day, October 29th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: A Markov model…
Oct 27, 2024, 17:41 | Blog
Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared on X: "S1803 Ph3…
Oct 26, 2024, 12:33 | Insight
Al-Ola A Abdallah: Will we soon see Belantamab back in relapse myeloma as part of a combination therapy?
Al-Ola A Abdallah, Associate Professor, Plasma Cell disorder program Director, Division of HMCT at University…
Oct 24, 2024, 20:28 | Blog
Vincent Rajkumar: Trials with bispecifics for myeloma going on in all stages of the disease
Vincent Rajkumar shared on X: ''Trials with bispecifics for myeloma going on in all stages…
Oct 20, 2024, 11:26 | Blog
Vincent Rajkumar: VRd transplant and Len maintenance for frontline therapy in newly diagnosed myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared on X: “While we recommend…
Oct 19, 2024, 14:14 | Blog
Stathis Kastritis received Robert Kyle award for contributions in Waldenstrom Macroglobulinemia
Since 2003, the IMF has honored an outstanding physician each year with the Robert A.…
Oct 12, 2024, 16:23 | Insight
Myeloma Paper of the Day, October 12th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Pharmacovigilance study of…
Oct 11, 2024, 16:19 | Insight
Myeloma Paper of the Day, October 11th, suggested by Robert Orlowski
Robert Orlowski shared about the Myeloma Paper of the Day. Read about the article on…
Oct 9, 2024, 16:49 | Blog
Vincent Rajkumar: mSMART Updated guidelines for newly diagnosed myeloma
Vincent Rajkumar shared on X: "Just out: mSMART Updated guidelines for newly diagnosed myeloma. Main…
Oct 9, 2024, 16:24 | Insight
Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells
Jonathan Licht, Director of the UF Health Cancer Center, shared a post on X: "Our…
Oct 8, 2024, 14:00 | Blog
Yan Leyfman: 2 weeks until the Lymphoma, Leukemia and Myeloma Congress
Yan Leyfman shared a post on LinkedIn: "Just 2 weeks until I'm attending the Lymphoma, Leukemia…
Oct 6, 2024, 12:26 | Blog
Vincent Rajkumar: Impact of the FDA accelerated approval pathway on myeloma
Vincent Rajkumar posted the following on X: “I estimate over 100,000 person years of life…
Oct 4, 2024, 09:38 | Insight
Myeloma Paper of the Day, October 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: In a cohort of 220 patients…
Sep 26, 2024, 17:47 | Insight
Charles Gaulin: Our initiative on enhancing advance care planning has received an ASCO Conquer Cancer Merit Award
Charles Gaulin shared a post on LinkedIn: "Excited to announce that our quality improvement initiative…
Sep 22, 2024, 13:33 | Insight
Ajay Nooka: This paper by Nisha S Joseph is not only practice changing manuscript but a very important milestone
Vincent Rajkumar shared a post by Ajay Nooka, Professor Dept. Hematology/Oncology at Emory School of Medicine, on…
Sep 13, 2024, 23:49 | Blog
Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting
Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…
Sep 6, 2024, 10:06 | Insight
Myeloma Paper of the Day, September 6th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study of cancer incidence data…
Sep 6, 2024, 08:25 | Blog
Conquering the terrain of Iceland to raise funds for IMFBSRI - International Myeloma Foundation
International Myeloma Foundation shared a post on X: "Join us in celebrating our group of myeloma…
Sep 3, 2024, 18:57 | Blog
Will you give up your coffee run for a brighter future for myeloma? - International Myeloma Foundation
International Myeloma Foundation shared on X: “Just $5 supports the International Myeloma Foundation's research, patient…
Aug 26, 2024, 21:33 | Blog
C. Ola Landgren: Lots of new data at the Hematology Society of Taiwan
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Aug 26, 2024, 21:19 | Blog
IMF Iceland Cycling Expedition: A rigorous journey to end myeloma
International Myeloma Foundation shared a post on X: “August 29 - September 3, 2024 We…
Aug 25, 2024, 09:29 | Insight
Rahul Banerjee: Fascinating Multiple Myeloma results of MajesTEC-1 in BCMA-exposed patients
Rahul Banerjee shared a post by Robert Z. Orlowski, Director of Myeloma Section at MD Anderson…
Aug 23, 2024, 06:50 | Insight
Martin Kaiser: Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma
Martin Kaiser, Reader in Molecular Haematology at The Institute of Cancer Research, shared on LinkedIn…
Aug 23, 2024, 06:22 | Blog
Highlights from the 2024 Seattle Cellular Therapy Summit
The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…
Aug 20, 2024, 16:28 | Blog
Robin Tuohy: 2 of the best myeloma doctors at the IMF Patient and Family Seminar
Robin Tuohy, Vice-President of Support Groups at International Myeloma Foundation⁦, shared a post on X:…
Aug 17, 2024, 19:47 | Blog
Marc Braunstein: Updates on CAR T-cell therapy in myeloma
Marc Braunstein, Associate Professor, Department of Medicine at NYU Grossman Long Island School of Medicine, shared…
Aug 17, 2024, 12:14 | Dialogues
ASCO24 Updates: Is Combined Imaging the Key to Improved Myeloma Treatment?
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Aug 15, 2024, 14:47 | Insight
Myeloma Paper of the Day, August 15th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: MYEOV locus, which is over-expressed…
Aug 14, 2024, 15:35 | Blog
Vincent Rajkumar: Updated Active Drugs in myeloma with mechanism of action
Vincent Rajkumar shared a post on X: "Updated Active Drugs in myeloma with mechanism of…
Aug 12, 2024, 12:56 | Insight
Vincent Rajkumar: Treatment of newly diagnosed myeloma in one slide
Vincent Rajkumar shared on X: "Treatment of newly diagnosed myeloma in one slide. Based on…
Aug 12, 2024, 12:52 | Blog
Erik Ellefsen: Got to share a bit of my myeloma story at OCS and met another myeloma warrior
Erik Ellefsen, Cancer Survivor and Patient Advocate, shared on X: "Got to share a bit…
Aug 12, 2024, 02:23 | Blog
Rafael Fonseca: Defining CRS and ICANs risks
Rafael Fonseca shared a post by USMIRC News, on X: "Clearly defines risk of CRS and…
Aug 7, 2024, 17:10 | Blog
Saad Usmani joins the International Myeloma Foundation for IMF's Iceland Cycling Expedition
International Myeloma Foundation (IMF) shared on X: "Dr. Saad Usmani first took interest in myeloma…
Aug 4, 2024, 11:30 | Blog
Vincent Rajkumar reflects on FDA approval of Dara-VRd for newly diagnosed myeloma
Vincent Rajkumar shared a post on X: "FDA approves Dara-VRd for newly diagnosed myeloma. Quads…
Aug 2, 2024, 23:39 | Blog
The efficacy of BMA and the role of precision medicine in Myeloma
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Aug 1, 2024, 04:58 | Insight
Real-world data to describe myeloma management and outcomes
Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne…
Aug 1, 2024, 04:52 | Blog
Rahul Banerjee: Pleasure to be interviewed with Betsy O'Donnell about patient support group
Rahul Banerjee, Graduate Research Assistant at Duke University Pratt School of Engineering, shared CURE Today's…
Aug 1, 2024, 03:56 | Blog
New England Hematologic Diseases Symposium
Yale Cancer Center shared a post on X: ''We are partnering with Saint Francis Hospital…
Jul 30, 2024, 16:18 | Insight
Myeloma Paper of the Day, July 30th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Study of health-related quality of…
Jul 29, 2024, 21:02 | Blog
GDUHEM summarized by Rahul Banerjee
GDUHEM (The Great Debates and Updates in Hematologic Malignancies) event took place in Los Angeles…
Jul 28, 2024, 15:37 | Insight
Timing of Toxicities and Mortality Following CAR T Therapy in Myeloma
Al-Ola A Abdallah, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas Medical Center,…
All: 224 Posts: 1 - 100
Special Coverage